Obesity and Oncology

The link between obesity and risk for several kinds of cancer is currently well established by over a decade of scientific research. Overweight or obesity is liable for nearly twenty fifth of the relative contribution to cancer incidence that ranks second solely to tobacco use. Obesity is strongly tied to several of the most common types of cancers, are post-menopausal carcinomacolorectal cancer and cancers of the endometrium, kidney, thyroid and bladder. However, evidence is less convincing and somewhat controversial for prostate cancer, lung cancer and pre-menopausal breast cancer; several studies report an inverse relationship between obesity and these particular cancers.

    Related Conference of Obesity and Oncology

    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    September 14-15, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    September 28-29, 2026

    13th International Conference on Stroke and Neurological Disorders

    Amsterdam, Netherlands
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    January 18-19, 2027

    44th International Conference on Women's Health

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK
    May 17-18, 2027

    38th European Heart and Heart Failure Congress

    Paris, France

    Obesity and Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in